Snowball logo
logo
ARMP_logo

Armata Pharmaceuticals Inc

ARMP NYSE MKT
$5.38+$0.15  (2.87%)
Estimate
EPS
-5
Beta
1.329
Growth
Net income, YoY
554.99%
FCF, YoY
-17.98%
Forecast
EPS (FWD)
-1.4
About the company
Ticker
ARMP
ISIN
US04216R1023
Country
United States of America
Sector (GICS)
Healthcare
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA03 for Pseudomonas aeruginosa . The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc.

Frequently asked questions

What sector does Armata Pharmaceuticals Inc (ARMP) operate in?

Armata Pharmaceuticals Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Armata Pharmaceuticals Inc (ARMP) current stock price?

As of the latest data, Armata Pharmaceuticals Inc stock price is $5.38, with a previous close of $5.23. Armata Pharmaceuticals Inc gained $0.15 in the last trading session, representing a 2.87% increase.

What is Armata Pharmaceuticals Inc (ARMP) current market capitalization?

Armata Pharmaceuticals Inc market cap is approximately 197.50 million.

What is Armata Pharmaceuticals Inc (ARMP) Earnings Per Share (EPS)?

The trailing EPS is -$5.00, and the forward EPS is -$1.40.

Does Armata Pharmaceuticals Inc (ARMP) pay dividends?

No. Armata Pharmaceuticals Inc does not pay a dividend.

What is Armata Pharmaceuticals Inc (ARMP) beta (volatility) score?

Armata Pharmaceuticals Inc has a beta of 1.329, suggesting it is more volatile than the market.